$122 Million is the total value of PERKINS CAPITAL MANAGEMENT INC's 110 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 20.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AMD | Buy | ADVANCED MICRO DEVICES INC | $2,863,000 | +135.4% | 26,184 | +209.9% | 2.35% | +185.9% |
INUV | Buy | INUVO INC | $2,844,000 | -5.3% | 5,805,032 | +2.4% | 2.33% | +15.0% |
AXGN | Buy | AXOGEN INC | $2,288,000 | -11.9% | 288,190 | +4.0% | 1.88% | +7.0% |
ATEC | Buy | ALPHATEC HLDGS INC | $2,007,000 | +5.1% | 174,500 | +4.4% | 1.64% | +27.6% |
ATRS | Buy | ANTARES PHARMA INC | $1,974,000 | +15.9% | 481,483 | +0.9% | 1.62% | +40.7% |
RMTI | Buy | ROCKWELL MED INC | $1,947,000 | +60.6% | 4,130,175 | +39.7% | 1.60% | +95.1% |
BTTR | Buy | BETTER CHOICE CO INC | $1,709,000 | +71.8% | 670,000 | +117.5% | 1.40% | +108.5% |
XGN | Buy | EXAGEN INC | $1,614,000 | -30.4% | 200,975 | +0.8% | 1.32% | -15.5% |
QUIK | Buy | QUICKLOGIC CORP | $1,357,000 | +9.8% | 246,782 | +2.1% | 1.11% | +33.3% |
AKTS | Buy | AKOUSTIS TECHNOLOGIES INC | $1,264,000 | -1.9% | 194,450 | +0.8% | 1.04% | +19.1% |
BIOL | Buy | BIOLASE INC | $1,083,000 | -8.8% | 3,066,030 | +0.6% | 0.89% | +10.7% |
VFF | Buy | VILLAGE FARMS INTL INC | $961,000 | -4.9% | 182,050 | +15.6% | 0.79% | +15.4% |
T | Buy | AT&T INC | $941,000 | -0.2% | 39,837 | +3.9% | 0.77% | +21.0% |
Buy | JOURNEY MED CORP | $926,000 | +22.2% | 191,750 | +36.2% | 0.76% | +48.2% | |
AGFY | Buy | AGRIFY CORP | $562,000 | -45.1% | 121,285 | +9.0% | 0.46% | -33.3% |
CSII | Buy | CARDIOVASCULAR SYSTEMS INC DEL | $553,000 | +26.8% | 24,450 | +5.4% | 0.45% | +54.1% |
QUMU | Buy | QUMU CORP | $524,000 | -11.9% | 297,700 | +6.1% | 0.43% | +7.0% |
AQB | Buy | AQUABOUNTY TECHNOLOGIES INC | $523,000 | -4.0% | 279,500 | +7.7% | 0.43% | +16.6% |
New | CEA INDUSTRIES INC | $502,000 | – | 200,000 | +100.0% | 0.41% | – | |
New | AVINGER INC | $456,000 | – | 125,539 | +100.0% | 0.37% | – | |
VVOS | Buy | VIVOS THERAPEUTICS INC | $402,000 | +31.4% | 150,050 | +10.3% | 0.33% | +59.4% |
IRIX | Buy | IRIDEX CORP | $321,000 | -17.5% | 69,346 | +8.8% | 0.26% | 0.0% |
VEV | New | VICINITY MOTOR CORP | $319,000 | – | 133,000 | +100.0% | 0.26% | – |
VRAY | Buy | VIEWRAY INC | $130,000 | -8.5% | 33,200 | +29.2% | 0.11% | +11.5% |
NBSE | Buy | NEUBASE THERAPEUTICS INC | $125,000 | +48.8% | 66,500 | +121.7% | 0.10% | +78.9% |
New | MODULAR MED INC | $110,000 | – | 25,000 | +100.0% | 0.09% | – | |
AMRN | Buy | AMARIN CORP PLCspons adr new | $82,000 | -1.2% | 25,000 | +2.0% | 0.07% | +19.6% |
APYX | New | APYX MEDICAL CORPORATION | $67,000 | – | 10,300 | +100.0% | 0.06% | – |
SENS | Buy | SENSEONICS HLDGS INC | $51,000 | -13.6% | 26,000 | +18.2% | 0.04% | +5.0% |
ATHX | Buy | ATHERSYS INC NEW | $44,000 | -17.0% | 72,000 | +22.0% | 0.04% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-04-20
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NEOGENOMICS INC | 41 | Q3 2023 | 7.8% |
LILY ELI & CO | 41 | Q3 2023 | 6.9% |
PFIZER INC | 41 | Q3 2023 | 2.9% |
ATTUNITY LTD | 41 | Q3 2023 | 3.6% |
EXPEDITORS INTL WASH INC | 41 | Q3 2023 | 2.3% |
CVS HEALTH CORP | 41 | Q3 2023 | 1.6% |
DONALDSON INC | 41 | Q3 2023 | 1.3% |
VERIZON COMMUNICATIONS INC | 41 | Q3 2023 | 1.0% |
US BANCORP DEL | 41 | Q3 2023 | 0.8% |
BAXTER INTL INC | 40 | Q3 2023 | 14.1% |
View PERKINS CAPITAL MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
BIOLASE, INC | May 15, 2023 | 689,196 | 2.1% |
FlexShopper, Inc. | February 09, 2023 | 1,281,460 | 5.9% |
Avinger Inc | February 14, 2020 | 891,761 | 5.2% |
Black Ridge Oil & Gas, Inc. | February 15, 2019 | 30,021,032 | 6.3% |
CANCER GENETICS, INC | February 15, 2019 | 1,135,250 | 4.0% |
TearLab Corp | February 15, 2019 | 1,666,294 | 13.1% |
Xtant Medical Holdings, Inc. | February 15, 2019 | 684,408 | 3.6% |
TearLab Corp | January 26, 2018 | 4,300,655 | 40.1% |
BIO KEY INTERNATIONAL INC | February 09, 2017 | 274,900 | 4.4% |
EnteroMedics Inc | February 09, 2017 | 1,455 | 0.0% |
View PERKINS CAPITAL MANAGEMENT INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-01-22 |
13F-HR | 2023-11-02 |
13F-HR | 2023-07-21 |
SC 13G/A | 2023-05-15 |
13F-HR | 2023-05-09 |
SC 13G/A | 2023-02-09 |
SC 13G | 2023-02-09 |
13F-HR | 2023-01-26 |
13F-HR | 2022-10-24 |
13F-HR | 2022-07-29 |
View PERKINS CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.